NMDA receptor drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (10)
Papers in which this entity is mentioned.
- Reduction of APOE accounts for neurobehavioral deficits in fetal alcohol spectrum disorders. (2024)
- Simultaneous single cell measurements of intranuclear proteins and gene expression (2021)
- A comparison of word embeddings for the biomedical natural language processing. (2018)
- An in vivo 1H magnetic resonance spectroscopy study of the deep cerebellar nuclei in children with fetal alcohol spectrum disorders. (2014)
- Fetal alcohol spectrum disorders: experimental treatments and strategies for intervention. (2011)
- Fetal alcohol spectrum disorders: research challenges and opportunities. (2011)
- The effects of a single memantine treatment on behavioral alterations associated with binge alcohol exposure in neonatal rats. (2011)
- Imaging the impact of prenatal alcohol exposure on the structure of the developing human brain. (2011)
- Structural, metabolic, and functional brain abnormalities as a result of prenatal exposure to drugs of abuse: evidence from neuroimaging. (2010)
- Prenatal choline supplementation mitigates the adverse effects of prenatal alcohol exposure on development in rats. (2009)
Merged raw entities (9)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| nmda receptor | drug | 120 | 297 |
| nmda receptor | gene | 19 | 27 |
| nmda receptors | drug | 19 | 21 |
| nmda receptor | phenotype | 8 | 11 |
| n-methyl-d-aspartate receptor | drug | 8 | 8 |
| nmdars | drug | 2 | 2 |
| nmda system | drug | 1 | 1 |
| nmda receptor activity | drug | — | — |
| n-methyl-d-aspartic acid receptor | drug | — | — |